No abstract

No abstract

Peripartum cardiomyopathy is a form of idiopathic systolic heart failure which occurs during the end of pregnancy or the early post-partum in the absence of an identifiable etiology. The exact pathogenesis remains unknown, and the incidence is higher in African ancestry, multiparous and hypertensive women, or older maternal age. Delay in diagnosis is common, mainly because symptoms of heart failure mimic those of normal pregnancy. Echocardiography showing decreased myocardial function is at the center of the diagnosis. Management relies on the general guidelines of management of other forms of non-ischemic cardiomyopathy; however, special attention should be paid when choosing medications to ensure fetal safety. Outcomes can be variable and can range from complete recovery to persistent heart failure requiring transplant or even death. High rates of relapse with subsequent pregnancies can occur, especially with incomplete myocardial recovery. Additional research about the etiology, experimental drugs, prognosis, and duration of treatment after recovery are needed.

No abstract

Prosthetic valve thrombosis, a serious complication of prosthetic valve replacement, can be lethal without proper treatment. Right-sided valve thrombosis is rare but several therapeutic modalities can be considered: anticoagulation therapy, fibrinolysis, or surgery. Here, we report a case of significant tricuspid valve thrombosis which failed fibrinolytic therapy requiring repeat sternotomy with repeat tricuspid valve replacement with a porcine bioprosthesis.

Cardiovascular diseases, including heart disease and stroke, are the world’s largest killers. More than 800,000 people die from cardiovascular disease each year in the United States (US). Heart disease is estimated to cost 200 billion US Dollars (USD) annually. Early identification of an inexpensive marker which allows for early intervention is the need of the hour. We present a case describing one such marker which can be easily appreciated on physical examination. Several studies have shown, not only the association between the presence of the diagonal earlobe crease (DELC) and coronary artery disease (CAD) but also a correlation with the extent and severity of CAD, independent of cardiovascular risk factors.Our patient who had no known CAD or risk factors presented with an acute coronary syndrome (ACS). On exam, he was noted to have bilateral DELC. Over the course of his workup, he was noted to have severe triple vessel disease and eventually underwent surgical revascularization. We seek to increase awareness of this valuable physical sign which has far-reaching consequences in the prognostication and risk stratification of patients.

Erectile dysfunction (ED) is a common condition with a significant impact on the quality of life. Regenerative medicine maladies are intended to repair or replace damaged tissues and organs through different therapeutic mechanisms. Our aim was to study the effect of intra‐corporeal injection (ICI) of platelet‐rich plasma (PRP) in ED patients. Thirty‐four patients’ erectile function was evaluated by filling up an abridged form of the international index of erectile function (IIEF‐5) before and after PRP therapy. ICI of PRP was done once per week for 2 months. All patients were prescribed PDE5Is for one month after PRP therapy. Penile haemodynamics was assessed using 20 µg of PGE1 before and 3 months after initiating PRP therapy. Interestingly, our study had shown that there was a statistically significant difference in the IIEF‐5 score after ICI of PRP (−5.5, ±5.2, p=<0.001). Furthermore, in multiple logistic regression model for PRP responsiveness, smoking and IIEF score before PRP were the only significant independent variables (p = .040, p = .023 respectively). PRP injection for ED patients may be a promising modality as well as baseline IIEF‐5, and smoking status can be used as predictors for a satisfactory response to PRP in such patients.

Background: Hyperglycemia is common among critically ill patients and is associated with increased morbidity and mortality and there is no clear answer to the question: which to apply tight or conventional glycemic control? Objective: Evaluation and comparison of the effects of tight versus conventional glycemic control on critically ill patients in our surgical intensive care unit (ICU). Design: Prospective randomized controlled trial. Methods: 120 Patients were divided into two groups: group (I) received intensive insulin therapy targeting blood glucose level between 80 and 110 mg/dl, who referred to as intensive treatment group, and group (II) received conventional insulin therapy targeting blood glucose level between 150 and 200 mg/dl, and referred to as conventional treatment group. Results: 120 Patients were enrolled in the study, the incidence of hypoglycemia (blood glucose <70 mg/dl) was 29.09% in group I who received intensive insulin therapy versus 6.15% in group II who received conventional insulin therapy (p value 0.000) with no demonstrable complications, regarding mortality rate, impairment of Liver function tests, change in total leukocytic count, the need for red blood cell transfusion, ICU stay and Total hospital stay and we reported no statistical significant difference between the two groups. Conclusion: Tight glycemic control for critically ill patients in ICU in poor resources countries showed increased incidence of hypoglycemia with no significant benefits when compared with conventional glycemic control.